Justice GCC
ar ع
  • Home
  • Legislation
  • Courts
  • Law Firms
  • Deals
Reading: Grünenthal Acquires Bayer Cancer Drug Stivarga for Up to $431 Million
Share
Justice GCCJustice GCC
Font ResizerAa
  • Legislation
  • Courts
  • Law Firms
  • Deals
Search
  • Home
  • Legislation
  • Courts
  • Law Firms
  • Deals
  • About
  • Corrections
  • Editorial Policy
  • Contact
Justice GCC > Deals > Grünenthal Acquires Bayer Cancer Drug Stivarga for Up to $431 Million
Deals

Grünenthal Acquires Bayer Cancer Drug Stivarga for Up to $431 Million

NewsDesk
Last updated: September 23, 2026 2:35 pm
NewsDesk
Share
Grünenthal Acquires Bayer Cancer Drug Stivarga | AI-Generated Image
SHARE

Grünenthal Group said in a statement that it reached an agreement with Bayer AG to acquire Stivarga, an oral multikinase inhibitor also known as regorafenib, for up to 375 million euros. The deal covers global rights to the medicine, which is indicated for metastatic colorectal cancer, hepatocellular carcinoma and gastrointestinal stromal tumours in patients who have already received other treatments or cannot be given them. The acquisition remains subject to regulatory approvals and other customary conditions, with both parties anticipating a close by the end of 2026 or early 2027.

According to Grünenthal’s announcement, Stivarga holds approvals and is marketed in more than 90 countries, though patent protection is projected to expire in 2029 in the European Union and 2030 in the United States. Bayer reported an 18 percent drop in first-half 2026 sales to 148 million euros, which the company linked to China’s centralized tender program for off-patent drugs. Full-year sales in 2025 totaled 338 million euros, reflecting a roughly 25 percent decline from the previous year.

Gabriel Baertschi, chief executive of Grünenthal, said in the announcement, “This acquisition is a strong strategic fit for Grünenthal and reflects our disciplined M&A strategy of acquiring established medicines that address clear and ongoing medical needs and create long-term value.” The buyer, which has committed around 2.6 billion euros to M&A deals since 2017, projects that Stivarga could contribute up to 100 million euros to consolidated EBITDA in 2027 if the transaction closes as scheduled and receives full-year consolidation. Grünenthal described the purchase as the latest move to leverage its commercial and operational strengths for sustained growth.

The transaction arrives weeks after Bayer completed the sale of a minority stake in its long-acting reversible contraceptives business to Apollo Global Management for approximately 3 billion euros. For the seller, divesting the mature oncology asset frees resources to concentrate on newer pharmaceutical candidates as exclusivity periods near their end. Such portfolio pruning has become routine among large drugmakers seeking to streamline operations around high-potential pipelines.

Baker McKenzie advised Bayer on the sale while Freshfields Bruckhaus Deringer counseled Grünenthal, according to statements issued by the respective law firms. The Baker McKenzie engagement supported the transfer of worldwide rights to the established treatment across multiple regulatory environments. This legal framework ensured all aspects of the complex cross-border deal met applicable requirements.

Grünenthal, headquartered in Aachen and recognized as a global leader in pain management and research, continues to expand through targeted acquisitions that enhance profitability and support its development pipeline. The addition of Stivarga broadens the company’s therapeutic footprint into oncology while building on existing infrastructure for commercialization. Pharmaceutical industry data show similar transfers of legacy products from multinational corporations to specialized buyers remain active as patent cliffs approach.

Share This Article
Email Copy Link Print
ByNewsDesk
Justice GCC NewsDesk is the desk responsible for Justice GCC's daily news coverage, monitoring and reporting developments across the Gulf from official sources, including national news agencies and government communications. Its focus is accurate, timely and factual coverage of the region.
Previous Article FSA Regulates Investment Banking to Strengthen Oman’s Capital Market Framework
Next Article Dubai Cassation Court Orders Asset Confiscation in Major Crypto Money Laundering Conviction

Popular Posts

Saudi Court Sentences Kenyan Migrant Worker to 100 Lashes for Extramarital Birth

A Saudi court sentenced Kenyan domestic worker Esther Wanja Muthoni to 100 lashes after she gave birth outside marriage in…

By
NewsDesk
3 Min Read
Emirates Drug Establishment First to Approve Ultomiris for Proteinuria in IgA Nephropathy

The Emirates Drug Establishment granted conditional approval on November 10, 2026 for…

5 Min Read
Baker McKenzie Recruits Data Protection Expert Kelly Hagedorn in London Lateral Move

Baker McKenzie announced the appointment of Kelly Hagedorn as a cybersecurity and…

3 Min Read

More News

Qatar Denounces Iranian Strikes on Kuwait and Bahrain as Breaches of Sovereignty

Qatar's Ministry of Foreign Affairs condemned renewed Iranian attacks on…

November 18, 2026

VAT Group Closes Atonarp Acquisition Financed by CHF 110 Million Bilateral Loan

VAT Group completed the acquisition of…

November 18, 2026

Natroshvili Expands Business Portfolio With UAE Legal Advisory Launch

David Natroshvili, ranked the most influential…

November 17, 2026

Iran Condemns Bahrain’s Life Sentences for Shia Clerics as Rights Abuse

Iran's Foreign Ministry on November 17,…

November 17, 2026

Bahraini Court Sentences 64 to Life in Prison Over Alleged Iran Links

A Bahraini court on November 16…

November 17, 2026

Recommended for You

Deals

Sadio Mane Rescues Al Nassr with Late Goal in Dramatic Saudi League Victory

Sadio Mane scored a late winner to save Al Nassr from defeat in a Saudi Pro League match on February…

2 Min Read
Deals

Dubai Investments Launches UAE’s First IPO of 2026 With Stake Sale in DIP Holding

Dubai Investments announced on October 19, 2026, that it will sell a 20 percent stake in subsidiary DIP Holding through…

4 Min Read
Deals

US Core Capital Goods Orders Advance 1.6 Percent in August Release

US core capital goods orders rose 1.6 percent in August 2026 after an upward revision to the prior month, Commerce…

3 Min Read
Deals

Sheikh Mohamed bin Zayed Receives Official Reception at Berlin Villa on Germany Visit

UAE President Sheikh Mohamed bin Zayed Al Nahyan was welcomed by German President Frank-Walter Steinmeier at Villa Borsig in Berlin…

3 Min Read

Categories

  • Legislation
  • Courts
  • Law Firms
  • Deals

Quick Links

  • About
  • Corrections
  • Editorial Policy
  • Contact
Justice GCC
© 2026 Justice GCC. Published by Peninsula News Group LLC. All rights reserved.
  • Privacy Policy
  • Terms of Use
  • Contact
Welcome to Foxiz

Sign in to your account

Username or Email Address
Password

Lost your password?